BUSILVEX

This brand name is authorized in Austria, Brazil, Estonia, Finland, France, Ireland, Lithuania, Netherlands, Poland, South Africa, Spain, Turkey, UK.

Active ingredients

The drug BUSILVEX contains one active pharmaceutical ingredient (API):

1	Busulfan UNII G1LN9045DK - BUSULFAN
	Busulfan is a potent cytotoxic agent and a bifunctional alkylating agent. In aqueous media, release of the methanesulphonate groups produces carbonium ions which can alkylate DNA, thought to be an important biological mechanism for its cytotoxic effect.
	Read more about Busulfan

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BUSILVEX Concentrate for solution	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01AB01	Busulfan	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AB Alkyl sulfonates
Discover more medicines within L01AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	507003901156311
EE	Ravimiamet	1178254
ES	Centro de información online de medicamentos de la AEMPS	03254002
FI	Lääkealan turvallisuus- ja kehittämiskeskus	130309
FR	Base de données publique des médicaments	65643325
GB	Medicines & Healthcare Products Regulatory Agency	75334
LT	Valstybinė vaistų kontrolės tarnyba	1027743, 1085238
NL	Z-Index G-Standaard	15005933
NL	Z-Index G-Standaard, PRK	129232
PL	Rejestru Produktów Leczniczych	100126531
TR	İlaç ve Tıbbi Cihaz Kurumu	8680683770029
ZA	Health Products Regulatory Authority	37/26/0668